Prilenia
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Prilenia sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).
Prilenia: 5 sponsored US clinical trials, 1 recruiting.
Prilenia sponsors 5 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 2 completed. 2 of these trials are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Amyotrophic Lateral Sclerosis, with 1 trials.
Upper-quartile sponsor footprint
Prilenia sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
5 total, page 1 of 1
Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS
NCT07322003
PRidopidine's Outcome On Function in Huntington Disease, PROOF- HD
NCT04556656
A Study to Assess the Safety and Effectiveness of Pridopidine Compared to Placebo in the Treatment of Levodopa-Induced Dyskinesia in Patients With Parkinson's Disease
NCT03922711
A Study Evaluating if Pridopidine is Safe, Efficacious, and Tolerable in Patients With Huntington's Disease
NCT02494778
A Phase 2, to Evaluating the Safety and Efficacy of Pridopidine Vs Placebo for Symptomatic Treatment in Patients With Huntington's Disease
NCT02006472
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 3 |
| Phase 3 | 2 |
Therapeutic Areas
What is open in the Prilenia pipeline
1 recruiting of 5 indexed (20% open); 2 completed (40%).
Phase mix: 2 late (III/IV) vs 3 early (I/II) (balanced across stages).
Top condition: Amyotrophic Lateral Sclerosis (1 trial), 0 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Prilenia: open-pipeline peers nationwide
Peers matched on 5 registered trials and 20% open enrollment, not the therapeutic-area sidebar.
Prilenia sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 5 trials (± recruiting share)
- 4YouandMe · 5 trials · 0% recruiting
- Abbott Rapid Dx · 5 trials · 0% recruiting
- Access Business Group · 5 trials · 0% recruiting
- Acera Surgical · 5 trials · 20% recruiting
Sponsors near 20% open enrollment (± trial volume)
- Align Technology · 20% recruiting · 5 trials
- AltruBio · 20% recruiting · 5 trials
- Alvernia University · 20% recruiting · 5 trials
- Amazentis · 20% recruiting · 5 trials
Related
What to do with this Prilenia page
5 registered trials is a research-attention snapshot, not an endorsement of Prilenia or any single study.
- 1 of Prilenia's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Amyotrophic Lateral Sclerosis is the condition Prilenia studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Amyotrophic Lateral Sclerosis trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Prilenia pipeline card: 5 registered trials from official public datasets.Report a data error.